MYELODYSPLASTIC SYNDROMES
Clinical trials for MYELODYSPLASTIC SYNDROMES explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROMES trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to keep leukemia at bay after transplant
Disease control CompletedThis early-phase trial tested a drug called ONC-201 in 20 people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who had recently received a stem cell transplant. The goal was to see if taking ONC-201 weekly for a year could help prevent the cancer f…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Apr 28, 2026 21:34 UTC
-
Which donor is best? study compares transplant survival strategies
Knowledge-focused CompletedThis study looked at 1,753 patients with blood cancers or blood disorders who needed a stem cell transplant but lacked a fully matched sibling donor. Researchers compared two strategies: first searching for a matched unrelated donor and then an alternative donor if needed, versus…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: NA • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Knowledge-focused
Last updated Apr 28, 2026 21:35 UTC